How is clinical presentation of HL?

Enlarging lymphadenopathy w/or w/out B symptoms, prognosis depends on stage generally good, even stage IV has 60-70% 5-year survival, CD markers CD15, CD30 (+) CD20 CD45 (-) except nodular lymphocyte predominant form (becomes reveresed)